85 related articles for article (PubMed ID: 11577529)
1. [Acute deep venous thrombosis and PET scanning with 2-fluoro-2-deoxy-D-glucose, FDG].
Jensen RB; Mortensen J; Dreyer M
Ugeskr Laeger; 2001 Sep; 163(38):5209-11. PubMed ID: 11577529
[TBL] [Abstract][Full Text] [Related]
2. Case report: internal and external jugular vein thrombosis with marked accumulation of FDG.
Kikuchi M; Yamamoto E; Shiomi Y; Nakamoto Y; Shiomi Y; Fujiwara K; Watanabe F; Shinohara S
Br J Radiol; 2004 Oct; 77(922):888-90. PubMed ID: 15483006
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report.
Miceli M; Atoui R; Walker R; Mahfouz T; Mirza N; Diaz J; Tricot G; Barlogie B; Anaissie E
J Clin Oncol; 2004 May; 22(10):1949-56. PubMed ID: 15143089
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
Hara T; Truelove J; Tawakol A; Wojtkiewicz GR; Hucker WJ; MacNabb MH; Brownell AL; Jokivarsi K; Kessinger CW; Jaff MR; Henke PK; Weissleder R; Jaffer FA
Circulation; 2014 Sep; 130(13):1044-52. PubMed ID: 25070665
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study.
Maisey NR; Webb A; Flux GD; Padhani A; Cunningham DC; Ott RJ; Norman A
Br J Cancer; 2000 Aug; 83(3):287-93. PubMed ID: 10917540
[TBL] [Abstract][Full Text] [Related]
9. Catheter-related focal FDG activity on whole body PET imaging.
Bhargava P; Kumar R; Zhuang H; Charron M; Alavi A
Clin Nucl Med; 2004 Apr; 29(4):238-42. PubMed ID: 15096970
[TBL] [Abstract][Full Text] [Related]
10. The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism.
Zhu HJ; Hess S; Rubello D; Goris ML; Alavi A
Nucl Med Commun; 2016 Mar; 37(3):322-8. PubMed ID: 26671850
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.
Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH
Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Becherer A; Mitterbauer M; Jaeger U; Kalhs P; Greinix HT; Karanikas G; Pötzi C; Raderer M; Dudczak R; Kletter K
Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.
Shreve PD; Anzai Y; Wahl RL
Radiographics; 1999; 19(1):61-77; quiz 150-1. PubMed ID: 9925392
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
[TBL] [Abstract][Full Text] [Related]
15. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
16. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Newman JS; Francis IR; Kaminski MS; Wahl RL
Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
[TBL] [Abstract][Full Text] [Related]
17. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
Giorgetti A; Volterrani D; Mariani G
Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.
Cremerius U; Fabry U; Neuerburg J; Zimny M; Bares R; Osieka R; Büll U
Nuklearmedizin; 2001 Feb; 40(1):23-30. PubMed ID: 11373935
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis.
Rondina MT; Lam UT; Pendleton RC; Kraiss LW; Wanner N; Zimmerman GA; Hoffman JM; Hanrahan C; Boucher K; Christian PE; Butterfield RI; Morton KA
Clin Nucl Med; 2012 Dec; 37(12):1139-45. PubMed ID: 23154470
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.
Tatsumi M; Cohade C; Nakamoto Y; Wahl RL
Radiology; 2003 Dec; 229(3):831-7. PubMed ID: 14593193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
